Alta Vista Ventures Ltd. announces $350,000 Private Placement
07.04.2016 | FSCwire
Vancouver - Alta Vista Ventures Ltd. (AVV-CSE) wishes to announce a non-brokered private placement of up to 7,000,000 units at a price of $0.05 per unit (a “Unit”) to raise a total of up to $350,000. Each Unit consists of one previously unissued common share and one transferable purchase warrant (a “Warrant) of the Company. Each Warrant will entitle the holder, on exercise, to purchase one additional common share of the Company (a “Warrant Share”) for a period of 12 (twelve) months from the date of issue of the Warrant. The Warrants will be exercisable at a price of $0.075 per share.Alta Vista intends to use the proceeds of the private placement for corporate purposes and new potential opportunities.
The Company did not complete the financing announced on Feb. 17, 2016 and it has been subsequently cancelled.
About Alta Vista Ventures:
Alta Vista has the right to purchase Thor Pharma, an early stage MMPR applicant that could add up to 75,000 square feet of growing space. Alta Vista cannot guarantee nor estimate the timing for the issuance of an MMPR license to Thor Pharma.
As part of its ongoing efforts to expand in the sector Alta Vista continues to evaluate additional opportunities.
On behalf of the Board,
“Don Shaxon”
Donald Shaxon, President
For information on Alta Vista Ventures, or Thor Pharma, please call Mr. Don Shaxon at 289-697-8625
Neither Canadian Securities Exchange (CSE) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Statements in this press release, other than purely historical information, including statements relating to the Company’s future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
